Altered gut microbiota in Taiwanese A97S predominant transthyretin amyloidosis with polyneuropathy. | Altered gut microbiota in Taiwanese A97S predominant transthyretin amyloidosis with polyneuropathy. Chen CC, Tseng PH, Hsueh HW, Chiang MC, Tzeng SR, Chiang TH, Wu MS, Hsieh ST, Chao CC., Free PMC Article | 03/19/2024 |
Rare c.302C>T TTR Variant Associated with Transthyretin Amyloidosis. | Rare c.302C>T TTR Variant Associated with Transthyretin Amyloidosis. Žebrauskienė D, Sadauskienė E, Masiulienė R, Aidietienė S, Šiaudinienė A, Pečeliūnas V, Žukauskaitė G, Žurauskas E, Valevičienė N, Barysienė J, Preikšaitienė E., Free PMC Article | 02/28/2024 |
Prevalence of transthyretin amyloid cardiomyopathy in patients admitted for acute heart failure. | Prevalence of transthyretin amyloid cardiomyopathy in patients admitted for acute heart failure. Spaccavento A, Rodríguez MDR, Meretta A, Elissamburu P, Carvelli V, Gobbo M, Rosa D, Masoli O, Conde D, Costabel JP. | 02/20/2024 |
Transthyretin-Regulated Diabetic Retinopathy Through the VEGFA/PI3K/AKT Pathway. | Transthyretin-Regulated Diabetic Retinopathy Through the VEGFA/PI3K/AKT Pathway. Liu L, Gao Y, Yao S., Free PMC Article | 01/31/2024 |
Mapping cellular response to destabilized transthyretin reveals cell- and amyloidogenic protein-specific signatures. | Mapping cellular response to destabilized transthyretin reveals cell- and amyloidogenic protein-specific signatures. Ghosh S, Villacorta-Martin C, Lindstrom-Vautrin J, Kenney D, Golden CS, Edwards CV, Sanchorawala V, Connors LH, Giadone RM, Murphy GJ. | 01/30/2024 |
Position statement on the non-invasive diagnosis of patients with ATTR pardiac amyloidosis, endorsed by the Hellenic Society of Nuclear Cardiology, for the Nuclear Medicine practitioners. | Position statement on the non-invasive diagnosis of patients with ATTR pardiac amyloidosis, endorsed by the Hellenic Society of Nuclear Cardiology, for the Nuclear Medicine practitioners. Koutelou M, Prassopoulos V, Lamprakos L, Zissimopoulos A, Chatzipanagiotou T, Mastorakou A, Doumas A. | 01/4/2024 |
Characterization of the G-quadruplexes in the transthyretin gene and its role in silencing transthyretin mRNA transcription. | Characterization of the G-quadruplexes in the transthyretin gene and its role in silencing transthyretin mRNA transcription. Huang P, Li X, Tan Z, Wang Y, Yan J. | 12/27/2023 |
Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis. | Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis. Steinebrei M, Baur J, Pradhan A, Kupfer N, Wiese S, Hegenbart U, Schönland SO, Schmidt M, Fändrich M., Free PMC Article | 11/27/2023 |
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS). | A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS). Gentile L, Coelho T, Dispenzieri A, Conceição I, Waddington-Cruz M, Kristen A, Wixner J, Diemberger I, Gonzalez-Moreno J, Cariou E, Maurer MS, Planté-Bordeneuve V, Garcia-Pavia P, Tournev I, Gonzalez-Costello J, Duarte AG, Grogan M, Mazzeo A, Chapman D, Gupta P, Glass O, Amass L, THAOS investigators., Free PMC Article | 11/15/2023 |
Decreased expression of S100A8/A9 in V30M related ATTRv amyloidosis. | Decreased expression of S100A8/A9 in V30M related ATTRv amyloidosis. Moreira J, Martins S, Saraiva M, Saraiva MJ. | 11/3/2023 |
Transthyretin promotes the invasion of combined hepatocellular cholangiocarcinoma by tumor-associated macrophages. | Transthyretin promotes the invasion of combined hepatocellular cholangiocarcinoma by tumor-associated macrophages. Ke K, Lin J, Huang N, Yan L, Liao R, Yang W., Free PMC Article | 10/30/2023 |
Musculoskeletal manifestations associated with transthyretin-mediated (ATTR) amyloidosis: a systematic review. | Musculoskeletal manifestations associated with transthyretin-mediated (ATTR) amyloidosis: a systematic review. Aldinc E, Campbell C, Gustafsson F, Beveridge A, Macey R, Marr L, Summers C, Zhang D., Free PMC Article | 09/28/2023 |
Cardiovascular Disease and Mortality in Black Women Carrying the Amyloidogenic V122I Transthyretin Gene Variant. | Cardiovascular Disease and Mortality in Black Women Carrying the Amyloidogenic V122I Transthyretin Gene Variant. Haring B, Hunt RP, Shadyab AH, Eaton C, Kaplan R, Martin LW, Panjrath G, Kuller LH, Assimes T, Kooperberg C, Wassertheil-Smoller S., | 09/13/2023 |
Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study. | Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study. Madhani A, Sabogal N, Massillon D, Paul LD, Rodriguez C, Fine D, Helmke S, Winburn M, Kurian D, Raiszadeh F, Teruya S, Cohn E, Einstein AJ, Miller EJ, Connors LH, Maurer MS, Ruberg FL., Free PMC Article | 08/30/2023 |
Hereditary transthyretin amyloidosis caused by p.Ser43Asn variant. A new endemic variant in Ecuador. | Hereditary transthyretin amyloidosis caused by p.Ser43Asn variant. A new endemic variant in Ecuador. Porres-López E, de Frutos F, Silva-Hernández L, Galán L, González-López E, García-Pavía P. | 06/30/2023 |
Transthyretin derived amyloid deposits in the atrium and the aortic valve: insights from multimodality evaluations and mid-term follow up. | Transthyretin derived amyloid deposits in the atrium and the aortic valve: insights from multimodality evaluations and mid-term follow up. Okada A, Kakuta T, Tadokoro N, Tateishi E, Morita Y, Kitai T, Amaki M, Kanzaki H, Ohta-Ogo K, Ikeda Y, Fukushima S, Fujita T, Kusano K, Noguchi T, Izumi C., Free PMC Article | 06/7/2023 |
Prevalence of transthyretin-related amyloidosis in Tuscany: Data from the regional population-based registry. | Prevalence of transthyretin-related amyloidosis in Tuscany: Data from the regional population-based registry. Cappelli F, Del Franco A, Vergaro G, Mazzoni C, Argirò A, Pieroni M, Giacomin E, Poli S, Allinovi M, Olivotto I, Pieroni F, Scaletti C, Emdin M, Perfetto F. | 05/17/2023 |
Ser77Tyr transthyretin amyloidosis in Israel: Initial manifestations and diagnostic features. | Ser77Tyr transthyretin amyloidosis in Israel: Initial manifestations and diagnostic features. Dori A, Arad M, Wasserstrum Y, Pollak A, Nikitin V, Ben-David M, Shamash J, Nahum AH, Shavit-Stein E, Domachevsky L, Kuperstein R, Dominissini D, Shelestovich N, Sadeh M, Pras E, Greenbaum L., Free PMC Article | 04/20/2023 |
A molecular basis for tetramer destabilization and aggregation of transthyretin Ala97Ser. | A molecular basis for tetramer destabilization and aggregation of transthyretin Ala97Ser. Wang YS, Huang CH, Liou GG, Hsueh HW, Liang CT, Tseng HC, Huang SJ, Chao CC, Hsieh ST, Tzeng SR., Free PMC Article | 04/4/2023 |
A review of transthyretin cardiac amyloidosis. | A review of transthyretin cardiac amyloidosis. Jhawar N, Moreno JCL, Chirila R. | 03/23/2023 |
Human transthyretin gene expression is markedly increased in repair Schwann cells in an in vitro model of hereditary transthyretin amyloidosis. | Human transthyretin gene expression is markedly increased in repair Schwann cells in an in vitro model of hereditary transthyretin amyloidosis. Murakami T, Ito Y, Sango K, Watabe K, Sunada Y. | 03/15/2023 |
Transthyretin cardiac amyloidosis. | Transthyretin cardiac amyloidosis. Porcari A, Fontana M, Gillmore JD., Free PMC Article | 02/15/2023 |
CSF/plasma levels, transthyretin stabilisation and safety of multiple doses of tolcapone in subjects with hereditary ATTR amyloidosis. | CSF/plasma levels, transthyretin stabilisation and safety of multiple doses of tolcapone in subjects with hereditary ATTR amyloidosis. Takahashi Y, Ohashi N, Takasone K, Yoshinaga T, Yazaki M, Roberts M, Glidden PF, Sekijima Y. | 09/24/2022 |
The genetics of cardiac amyloidosis. | The genetics of cardiac amyloidosis. Arno S, Cowger J. | 08/27/2022 |
Evidence From Human Placenta, Endoplasmic Reticulum-Stressed Trophoblasts, and Transgenic Mice Links Transthyretin Proteinopathy to Preeclampsia. | Evidence From Human Placenta, Endoplasmic Reticulum-Stressed Trophoblasts, and Transgenic Mice Links Transthyretin Proteinopathy to Preeclampsia. Cheng S, Huang Z, Banerjee S, Jash S, Buxbaum JN, Sharma S., Free PMC Article | 07/30/2022 |